Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

A middle school student curious about science grows into a college-bound scientist.

Compound offers a potential tool for fighting drug-resistant malaria parasites.

New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.